Ruba Ismail

Pharmacology, Toxicology and Pharmaceutics · Life Sciences

11h-index685citations21works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Drug Delivery Systems(17), Drug Solubulity and Delivery Systems(10), Nanoparticle-Based Drug Delivery(5), Advancements in Transdermal Drug Delivery(5), Diabetes Treatment and Management(4)

Publications21 total

Application of biorelevant in vitro assays for the assessment and optimization of ASD-based formulations for pediatric patients
European Journal of Pharmaceutics and Biopharmaceutics·2023· 6 cited
Development and Characterization of n-Propyl Gallate Encapsulated Solid Lipid Nanoparticles-Loaded Hydrogel for Intranasal Delivery
Pharmaceuticals·2021· 27 citedOpen Access
A comparison study of lipid and polymeric nanoparticles in the nasal delivery of meloxicam: Formulation, characterization, and in vitro evaluation
International Journal of Pharmaceutics·2021· 64 citedOpen Access
Regulatory status quo and prospects for biosurfactants in pharmaceutical applications
Drug Discovery Today·2021· 41 citedOpen Access
Lipid-based nanosystems for the nose-to-brain delivery of biological drug, Insulin
2021Open Access
Nose to brain delivery of n-propylgallte loaded lipid nanoparticles for targeting glioblastoma multiforme via QbD approach
2021· 1 citedOpen Access
What are the regulatory aspects surrounding nanopharmaceuticals development?
2021Open Access
Development and Optimization of n-Propyl Gallate-Encapsulated Hyaluronic Acid-Based Hydrogel for Nose-to-Brain Delivery Applying Quality-by-Design Methodology
2020· 2 citedOpen Access
The Effect of Counterions in Hydrophobic Ion Pairs on Oral Bioavailability of Exenatide
ACS Biomaterials Science & Engineering·2020· 36 citedOpen Access
Quality by design driven development of polymeric and lipid-based nanocarriers as potential systems for oral delivery of glp-1 analogues
2020· 3 citedOpen Access
Hydrophobic ion pairing of a GLP-1 analogue for incorporating into lipid nanocarriers designed for oral delivery
European Journal of Pharmaceutics and Biopharmaceutics·2020· 40 citedOpen Access
Progress and perspectives of brain-targeting lipid-based nanosystems via the nasal route in Alzheimer’s disease
European Journal of Pharmaceutics and Biopharmaceutics·2020· 99 cited
Potential of polymeric and Lipid based nanocarriers for oral GLP-1 analogue delivery
2020· 1 citedOpen Access
Encapsulation in Polymeric Nanoparticles Enhances the Enzymatic Stability and the Permeability of the GLP-1 Analog, Liraglutide, Across a Culture Model of Intestinal Permeability
Pharmaceutics·2019· 52 citedOpen Access
Nose-to-brain delivery of antiglioblastoma drugs embedded into lipid nanocarrier systems: status quo and outlook
Drug Discovery Today·2019· 89 citedOpen Access
Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery
Pharmaceutical Research·2019· 57 citedOpen Access
Quality by Design driven development of Liraglutide loaded nanocarriersystem designed for oral delivery
2019Open Access
Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development
European Journal of Pharmaceutical Sciences·2018· 49 cited
Up to date advances in nano-carrier systems for oral delivery of antidiabetic peptides
Journal of Nanomedicine & Nanotechnology·2017· 3 cited
Novel strategies in the oral delivery of antidiabetic peptide drugs – Insulin, GLP 1 and its analogs
European Journal of Pharmaceutics and Biopharmaceutics·2017· 113 cited
page 1 of 2Next →

Frequent Co-authors

Ildikó Csóka(17), Gábor Katona(7), Fakhara Sabir(5), Hussein Akel(3), Rita Ambrus(3), Thi Nhu Quynh Phan(2), Flavia Laffleur(2), Andreas Bernkop‐Schnürch(2), Tamás Sovány(1), Attila Gácsi(1), Norbert Imre(1), Alexandra Bocsik(1), Ilona Gróf(1), Mária A. Deli(1), Edina Pallagi(1), T Paál(1), Zain Baaity(1), Bao Le‐Vinh(1), Sergey Zaichik(1), Bence Sipos(1)